Not Yet RecruitingNot Applicable

Prospective Study on Monitoring Parotid Gland Injury After Radiotherapy for Head and Neck Tumors Using Multimodal Radiomics

20 participantsStarted 2025-01-20

Plain-language summary

Exploring a non-invasive and objective method for ultra early quantitative assessment of radiation-induced parotid gland injury. To provide a new and early method for evaluating changes in parotid gland function in clinical practice, and to guide the timing of interventions to protect the parotid gland.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Contraindications to MRI, such as metallic implants or claustrophobia.
✕. Severe comorbid conditions, including significant renal or hepatic dysfunction.
✕. Concurrent participation in another interventional clinical trial.
✕. Pregnant or breastfeeding.
✕. Any condition that may impair compliance with study procedures.
✕. Histologically or cytologically confirmed diagnosis of nasopharyngeal carcinoma.
✕. Scheduled to undergo radiotherapy as part of standard treatment.
✕. Aged 18 years or older.

What they're measuring

Quantitative assessment of salivary gland changes using IVIM and MRF imaging

Timeframe: From baseline to 3 months post-radiotherapy

Trial details

NCT IDNCT06792526

SponsorHainan People's Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-07-20

Contact for this trial

蔚吴

15689030575 ww1538067425@outlook.com

View on ClinicalTrials.gov More Xerostomia, Radiation-induced Parotid Damage,Predictivevalue,Head and Neck Cancer trials